BYSI (BYSI) Stock Price & Analysis
BYSI (BYSI) fell 0.66% to USD 0.62 as of September 8, 2026 at 06:22 UTC, according to Nexqual real-time market data.
BYSI last closed at USD 0.62; the session ranged USD 0.6–0.65 on volume of 26,549 shares. Market capitalization is —, with a 52-week range of USD 0.57–2.44 (NCM). Source: Nexqual, September 8, 2026 at 06:22 UTC.
Key Statistics (as of September 8, 2026 at 06:22 UTC)
| Price | USD 0.62 |
|---|---|
| Change | ▼ 0.66% (down) |
| Previous Close | USD 0.62 |
| Open | USD 0.62 |
| Day Range | USD 0.6 – 0.65 |
| 52-Week Range | USD 0.57 – 2.44 |
| Volume | 26,549 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (BYSI)
Nexqual's technical model rates BYSI "STRONG SELL" based on 0 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 06:22 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 30.17 (neutral) |
| vs SMA50 | Below (USD 1.08) |
| MACD | -0.13 (negative) |
From BYSI's Latest SEC 10-K Filing (filed 2026-03-25)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| FULC | Fulcrum Therapeutics, Inc. | USD 3.85 | ▲ 0% |
| VRPX | Virpax Pharmaceuticals, Inc. | USD 0 | ▲ 0% |
| ATXI | Avenue Therapeutics, Inc. | USD 0.54 | ▼ 4.56% |
| IPHA | Innate Pharma S.A. | USD 2.08 | ▼ 4.15% |
| ACIU | AC Immune SA | USD 2.86 | ▲ 0.7% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:22 UTC. This page is informational and not investment advice.